Altered adenosine-to-inosine RNA editing in human cancer von Paz, Nurit, Levanon, Erez Y, Amariglio, Ninette, Heimberger, Amy B, Ram, Zvi, Constantini, Shlomi, Barbash, Zohar S, Adamsky, Konstantin, Safran, Michal, Hirschberg, Avi, Krupsky, Meir, Ben-Dov, Issachar, Cazacu, Simona, Mikkelsen, Tom, Brodie, Chaya, Eisenberg, Eli, Rechavi, Gideon

Volltext

Major Histocompatibility Complex Class I Core Promoter Elements Are Not Essential for Transcription in vivo von Barbash, Zohar S., Weissman, Jocelyn D., Campbell, John A., Mu, Jie, Singer, Dinah S.

Volltext

Core promoter elements are not essential for transcription in mammals von Barbash, Zohar S, Weissman, Jocelvn D, Mu, Jie, Singer, Dinah S

Volltext

METHODS OF ANALYZING A-I RNA EDITING AND NUCLEIC ACID CONSTRUCTS CAPABLE OF SAME von RECHAVI, GIDEON, AMARIGLIO, NINETTE, BARBASH, ZOHAR S, SAFRAN, MICHAL

Volltext bestellen

A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks von Zimmerman, Lior, Zelichov, Ori, Aizenmann, Arie, Barbash, Zohar, Vidne, Michael, Tarcic, Gabi

Volltext

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma von Jin, Nan, Keam, Bhumsuk, Cho, Janice, Lee, Michelle J, Kim, Hye Ryun, Torosyan, Hayarpi, Jura, Natalia, Ng, Patrick Ks, Mills, Gordon B, Li, Hua, Zeng, Yan, Barbash, Zohar, Tarcic, Gabi, Kang, Hyunseok, Bauman, Julie E, Kim, Mi-Ok, VanLandingham, Nathan K, Swaney, Danielle L, Krogan, Nevan J, Johnson, Daniel E, Grandis, Jennifer R

Volltext

CCAAT Promoter element regulates transgenerational expression of the MHC class I gene von Weissman, Jocelyn D., Kotekar, Aparna, Barbash, Zohar, Mu, Jie, Singer, Dinah S.

Volltext

Abstract 1092: A systematic analysis of BRAF mutations and their sensitivity to different BRAF inhibitors von Barbash, Zohar, Haham, Dikla, Hafzadi, Liat, Zipor, Ron, Barth, Shaul, Aizenman, Arie, Zimmerman, Lior, Tarcic, Gabi

Volltext

Abstract 2447: Accurate prediction of the signaling pathway activity elicited by variants of uncertain significance (VUS) and their drug sensitivity using deep convolutional neural... von Zimmerman, Lior, Aizenman, Arie, Daitsh, Yutti, Barbash, Zohar, Tarcic, Gabi, Vidne, Michael

Volltext

Mapping the activation landscape of the MAPK\ERK pathway for variants of unknown significance (VUS) using convolutional neural networks (CNN) von Tarcic, Gabi, Zimmerman, Lior, Aizenman, Arie, Barbash, Zohar, Zelichov, Ori, Vidne, Michael

Volltext

Abstract 403: Analysis of RET solvent front mutations shows an effect on protein activity in tumor cells von Rotkopf, Shay, Haham, DIkla, Birnbaum, Lea, Barbash, Zohar, Tarcic, Gabi

Volltext

Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome von Kamal, Maud, Tarcic, Gabi, Dureau, Sylvain, Edelheit, Oded, Barbash, Zohar, Lecerf, Charlotte, Morel, Claire, Miron, Benjamin, Callens, Celine, Servant, Nicolas, Bieche, Ivan, Vidne, Michael, Le Tourneau, Christophe

Volltext

Abstract 1938: Large-scale identification of mutation activity and drug sensitivity in BRAF via a novel multi-label multi-task CNN model von Kifer, Ilona, Aizenman, Arie, Fillipov-Levy, Natalie, Barbash, Zohar, Vidne, Michael, Tarcic, Gabi

Volltext

Functional profiling of oncogenic mutations in lung cancer patients (NCT02274025): Interim results von Tarcic, Gabi, Peled, Nir, Barbash, Zohar, Edelheit, Oded, Vidne, Michael, Kramer, Mordechai R.

Volltext

Abstract 65: A novel tool for functional characterization of mutations and their response to targeted therapy von Barbash, Zohar, Haham, DIkla, Fillipov-Levy, Natalie, Cohen, Limor, Birnbaum, Lea, Rotkopf, Shay, Kifer, Ilona, Tarcic, Gabi

Volltext

Abstract 1162: A systematic analysis of RET mutations and their sensitivity to different RET inhibitors von Rotkopf, Shay, Haham, DIkla, Fillipov-Levy, Natalie, Birnbaum, Lea, Dehan, Elinor, Kifer, Ilona, Barbash, Zohar, Tarcic, Gabi

Volltext

Functional characterization of VUS mutations found in patients' cell-free circulating tumor DNA (ctDNA) using Precision Cancer Analysis System (PCAS) von Tarcic, Gabi, Simon, Daniel A., Jacobstein, Mark, Lanman, Richard Burnham, Vidne, Michael, Barbash, Zohar, Edelheit, Oded, Talasaz, AmirAli

Volltext

Functional characterization of non-V600 BRAF mutations and their response to Trametinib (Tram) von Sullivan, Ryan J., Barbash, Zohar, Edelheit, Oded, Vidne, Michael, Sosman, Jeffrey Alan, Flaherty, Keith, Davies, Michael A., Johnson, Douglas Buckner, Tarcic, Gabi

Volltext

Identification of the functional significance of mutations using the novel Precision Cancer Analysis System von Peled, Nir, Barbash, Zohar, Barabash-Katzir, Naama, Nevo, Hani, Vidne, Michael, Adamek, Mariusz, Kramer, Mordechai R., Goncharenko, Nikolai, Fellig, Yakov, Meir, Karen, Tarcic, Gabi

Volltext

Abstract 1379: Identification of the functional significance of mutations using the novel precision cancer analysis system von Tarcic, Gabi, Peled, Nir, Barbash, Zohar, Barabash-Katzir, Naama, Yaakobi, Shlomo, Nevo, Hani, Vidne, Michael, Adamek, Mariusz, Kramer, Mordechai R., Goncharenko, Nikolai, Fellig, Yakov, Meir, Karen, Mostov, Keith, Altschuler, Yoram

Volltext